| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||
Net loss | ||||||||
-87,930 | -92,877 | -87,404 | -76,418 | -68,808 | -46,037 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
6,533 | 5,317 | 4,307 | 3,491 | 2,835 | 2,354 | 0 | 0 | 0 |
Share-based compensation | ||||||||
10,496 | 8,940 | 8,075 | 5,876 | 3,852 | 2,453 | 0 | 0 | 0 |
Loss on disposal of property, equipment, and software | ||||||||
- | - | - | - | - | -14 | 0 | 0 | 0 |
Non-cash interest expense | ||||||||
- | 182 | 0 | 0 | 0 | - | - | - | - |
Change in fair value of convertible notes payable | ||||||||
- | 9,758 | 0 | 0 | 0 | - | - | - | - |
Amortization of right-of-use assets | ||||||||
0 | - | - | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses | ||||||||
-438 | 584 | 668 | 3,638 | 1,915 | 7,476 | 0 | 0 | 0 |
Accounts receivable | ||||||||
-2,299 | 441 | 0 | 0 | 0 | - | - | - | - |
Other assets and other current assets | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Other assets | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Accounts payable | ||||||||
-1,080 | 667 | -1,029 | -700 | 453 | -673 | 0 | 0 | 0 |
Accrued other expenses and other current liabilities | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Accrued expenses | ||||||||
- | - | - | - | - | - | - | 0 | 0 |
Deferred revenue | ||||||||
-11,952 | -7,866 | -6,065 | -4,420 | -1,009 | -3,177 | 0 | 0 | 0 |
Lease liabilities and right-of-use assets | ||||||||
0 | - | - | - | - | - | - | - | - |
Net cash used in operating activities | ||||||||
-77,018 | -71,015 | -63,371 | -64,441 | -57,176 | -51,723 | 0 | 0 | 0 |
Cash flows from investing activities: | ||||||||
Purchases of property, equipment and software | ||||||||
20,687 | 24,666 | 29,008 | 25,750 | 18,741 | 14,278 | 0 | 0 | 0 |
Net cash used in investing activities | ||||||||
-20,687 | -24,666 | -29,008 | -27,135 | -20,126 | -15,663 | 0 | 0 | 0 |
Cash flows from financing activities: | ||||||||
Proceeds from stock option exercises | ||||||||
1,366 | 1,261 | 502 | 468 | 258 | 171 | 0 | 0 | 0 |
Proceeds from employee stock purchase plan | ||||||||
0 | - | - | - | - | - | - | - | - |
Deferred offering costs | ||||||||
1,397 | 2,622 | 0 | 0 | 0 | - | - | - | - |
Issuance of convertible notes | ||||||||
- | 39,550 | 0 | 0 | 0 | - | - | - | - |
Net cash provided by financing activities | ||||||||
135,393 | 173,374 | 171,076 | 192,332 | 146,052 | 107,777 | 0 | 0 | 0 |
Net increase (decrease) in cash and cash equivalents | ||||||||
37,688 | 77,693 | 78,697 | 100,756 | 68,750 | 40,391 | 0 | 0 | 0 |
Supplemental disclosures of noncash financing and investing activities: | ||||||||
Property, equipment and software additions included in accounts payable, accrued expenses and other current liabilities | ||||||||
-2,899 | 401 | 2,677 | 2,304 | 4,639 | 1,340 | 0 | 0 | 0 |
Deferred offering costs included in accounts payable, accrued expenses and other current liabilities | ||||||||
0 | - | - | - | 0 | - | - | - | - |